Aneuploidy is defined as an abnormal karyotype that is not a multiple of the haploid complement.
Chromosome mis-segregation causes DNA damage.
Micronuclei form during chromosome mis-segregation. Chromosomes within micronuclei are under-replicated and undergo chromothripsis.
Chromosome mis-segregation leads to p53 activation.
The complex phenotypes caused by aneuploidy are produced by changes in the dosage of specific genes and a generic aneuploidy-associated stress response.
Aneuploidy causes proteotoxic stress and impairs proliferation.
Aneuploidy is a hallmark of cancer but the relationship between aneuploidy and cancer is complex. Depending on the context, aneuploidy can promote or antagonize malignant transformation.
Dividing cells that experience chromosome mis-segregation generate aneuploid daughter cells, which contain an incorrect number of chromosomes. Although aneuploidy interferes with the proliferation of untransformed cells, it is also, paradoxically, a hallmark of cancer, a disease defined by increased proliferative potential. These contradictory effects are also observed in mouse models of chromosome instability (CIN). CIN can inhibit and promote tumorigenesis. Recent work has provided insights into the cellular consequences of CIN and aneuploidy. Chromosome mis-segregation per se can alter the genome in many more ways than just causing the gain or loss of chromosomes. The short- and long-term effects of aneuploidy are caused by gene-specific effects and a stereotypic aneuploidy stress response. Importantly, these recent findings provide insights into the role of aneuploidy in tumorigenesis.
Subscribe to Journal
Get full journal access for 1 year
only $22.08 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Täckholm, G. Zytologische Studien über die Gattung Rosa. Acta Hort. Berg. 7, 97–381 (in German) (1922).
Holland, A. J. & Cleveland, D. W. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat. Rev. Mol. Cell Biol. 10, 478–487 (2009).
Holland, A. J. & Cleveland, D. W. Losing balance: the origin and impact of aneuploidy in cancer. EMBO Rep. 13, 501–514 (2012).
Pfau, S. J. & Amon, A. Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep. 13, 515–527 (2012).
Musacchio, A. & Salmon, E. D. The spindle-assembly checkpoint in space and time. Nat. Rev. Mol. Cell Biol. 8, 379–393 (2007).
Gordon, D. J., Resio, B. & Pellman, D. Causes and consequences of aneuploidy in cancer. Nat. Rev. Genet. 13, 189–203 (2012).
Upender, M. B. et al. Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res. 64, 6941–6949 (2004).
Lyle, R., Gehrig, C., Neergaard-Henrichsen, C., Deutsch, S. & Antonarakis, S. E. Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome. Genome Res. 14, 1268–1274 (2004).
Huettel, B., Kreil, D. P., Matzke, M. & Matzke, A. J. M. Effects of aneuploidy on genome structure, expression, and interphase organization in Arabidopsis thaliana. PLoS Genet. 4, e1000226 (2008).
Stingele, S. et al. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol. Syst. Biol. 8, 1–12 (2012).
Dephoure, N. et al. Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast. eLife 3, e03023 (2014). This paper reports that changes in gene copy number lead to corresponding changes in protein expression in 80% of budding yeast genes. It also reports the identification of a new gene expression signature that is characterized by the upregulation of proteins involved in the oxidative-stress response.
Kahlem, P. et al. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of Down syndrome. Genome Res. 14, 1258–1267 (2004).
Pavelka, N. et al. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 468, 321–325 (2010).
Torres, E. M. et al. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317, 916–924 (2007).
Vacík, T. et al. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes. Proc. Natl Acad. Sci. USA 102, 4500–4505 (2005).
Williams, B. R. et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322, 703–709 (2008).
Hassold, T. & Hunt, P. To err (meiotically) is human: the genesis of human aneuploidy. Nat. Rev. Genet. 2, 280–291 (2001).
Hanks, S. et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat. Genet. 36, 1159–1161 (2004).
Sears, D. D., Hegemann, J. H. & Hieter, P. Meiotic recombination and segregation of human-derived artificial chromosomes in Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 89, 5296–5300 (1992).
Hartwell, L. H. & Smith, D. Altered fidelity of mitotic chromosome transmission in cell cycle mutants of S. cerevisiae. Genetics 110, 381–395 (1985).
Brown, M. et al. Fidelity of mitotic chromosome transmission. Cold Spring Harb. Symp. Quant. Biol. 56, 359–365 (1991).
Storchova, Z. et al. Genome-wide genetic analysis of polyploidy in yeast. Nature 443, 541–547 (2006).
Thompson, S. L. & Compton, D. A. Examining the link between chromosomal instability and aneuploidy in human cells. J. Cell Biol. 180, 665–672 (2008).
Cimini, D., Tanzarella, C. & Degrassi, F. Differences in malsegregation rates obtained by scoring ana-telophases or binucleate cells. Mutagenesis 14, 563–568 (1999).
Rehen, S. K. et al. Constitutional aneuploidy in the normal human brain. J. Neurosci. 25, 2176–2180 (2005).
Knouse, K. A., Wu, J., Whittaker, C. A. & Amon, A. Single cell sequencing reveals low levels of aneuploidy across mammalian tissues. Proc. Natl Acad. Sci. 111, 13409–13414 (2014). This analysis shows that aneuploid karyotypes are rare in normal tissues.
Duncan, A. W. et al. Aneuploidy as a mechanism for stress-induced liver adaptation. J. Clin. Invest. 122, 3307–3315 (2012).
Duncan, A. W. et al. Frequent aneuploidy among normal human hepatocytes. Gastroenterology 142, 25–28 (2012).
Duncan, A. W. et al. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 467, 707–710 (2010).
Rehen, S. K. et al. Chromosomal variation in neurons of the developing and adult mammalian nervous system. Proc. Natl Acad. Sci. USA 98, 13361–13366 (2001).
Pack, S. D. et al. Individual adult human neurons display aneuploidy: detection by fluorescence in situ hybridization and single neuron PCR. Cell Cycle 4, 1758–1760 (2005).
Yurov, Y. B. et al. Aneuploidy and confined chromosomal mosaicism in the developing human brain. PLoS ONE 2, e558 (2007).
Faggioli, F., Wang, T., Vijg, J. & Montagna, C. Chromosome-specific accumulation of aneuploidy in the aging mouse brain. Hum. Mol. Genet. 21, 5246–5253 (2012).
McConnell, M. J. et al. Mosaic copy number variation in human neurons. Science 342, 632–637 (2013).
Cai, X. et al. Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain. Cell Rep. 8, 1280–1289 (2014).
Hassold, T. et al. Human aneuploidy: incidence, origin, and etiology. Environ. Mol. Mutagen. 28, 167–175 (1996).
Hartl, D. L. & Jones, E. W. Genetics: Analysis of Genes and Genomes (Jones & Bartlett Learning, 2005).
Janssen, A., van der Burg, M., Szuhai, K., Kops, G. J. P. L. & Medema, R. H. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333, 1895–1898 (2011). This paper shows that mis-segregating chromosomes can be damaged during cytokinesis and can be the source of structural chromosome aberrations in aneuploid daughter cells.
Crasta, K. et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53–58 (2012).
Hoffelder, D. et al. Resolution of anaphase bridges in cancer cells. Chromosoma 112, 389–397 (2004).
Terradas, M., Martín, M., Tusell, L. & Genescà, A. DNA lesions sequestered in micronuclei induce a local defective-damage response. DNA Repair 8, 1225–1234 (2009).
Terradas, M., Martín, M., Hernández, L., Tusell, L. & Genescà, A. Nuclear envelope defects impede a proper response to micronuclear DNA lesions. Mutat. Res. 729, 35–40 (2012).
Xu, B. et al. Replication stress induces micronuclei comprising of aggregated DNA double-strand breaks. PLoS ONE 6, e18618 (2011).
Newport, J. Nuclear reconstitution in vitro: stages of assembly around protein-free DNA. Cell 48, 205–217 (1987).
Hatch, E. M. et al. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell 154, 47–60 (2013).
Zhang, C.-Z. et al. Chromothripsis from DNA damage in micronuclei. Nature 522, 179–184 (2015). Using a combination of live-cell imaging and single-cell genome sequencing, this study provides the first evidence for a causative role of micronucleation in chromothripsis.
Liu, P. et al. Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements. Cell 146, 889–903 (2011).
Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27–40 (2011).
Forment, J. V., Kaidi, A. & Jackson, S. P. Chromothripsis and cancer: causes and consequences of chromosome shattering. Nat. Rev. Cancer 12, 663–670 (2012).
Zhang, C. Z., Leibowitz, M. L. & Pellman, D. Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev. 27, 2513–2530 (2013).
Thompson, S. L. & Compton, D. A. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J. Cell Biol. 188, 369–381 (2010). This study shows that chromosome mis-segregation leads to p53 activation, which limits the proliferation of aneuploid cells.
Dobles, M., Liberal, V., Scott, M. L., Benezra, R. & Sorger, P. K. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 101, 635–645 (2000).
Burds, A. A., Lutum, A. S. & Sorger, P. K. Generating chromosome instability through the simultaneous deletion of Mad2 and p53. Proc. Natl Acad. Sci. USA 102, 11296–11301 (2005).
Li, M. et al. The ATM–p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc. Natl Acad. Sci. 107, 14188–14193 (2010).
Uetake, Y. & Sluder, G. Prolonged prometaphase blocks daughter cell proliferation despite normal completion of mitosis. Curr. Biol. 20, 1666–1671 (2010).
Orth, J. D., Loewer, A., Lahav, G. & Mitchison, T. J. Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction. Mol. Biol. Cell 23, 567–576 (2012).
Hayashi, M. T., Cesare, A. J., Fitzpatrick, J. A. J., Lazzerini-Denchi, E. & Karlseder, J. A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest. Nat. Struct. Mol. Biol. 19, 387–394 (2012).
Blagosklonny, M. V., Demidenko, Z. N. & Fojo, T. Inhibition of transcription results in accumulation of Wt p53 followed by delayed outburst of p53-inducible proteins: p53 as a sensor of transcriptional integrity. Cell Cycle 1, 67–74 (2002).
Blagosklonny, M. V. Prolonged mitosis versus tetraploid checkpoint: how p53 measures the duration of mitosis. Cell Cycle 5, 971–975 (2006).
Demidenko, Z. N. et al. Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis. Oncogene 27, 4402–4410 (2008).
Tang, Y.-C., Williams, B. R., Siegel, J. J. & Amon, A. Identification of aneuploidy-selective antiproliferation compounds. Cell 144, 499–512 (2011).
Torres, E. M., Williams, B. R. & Amon, A. Aneuploidy: cells losing their balance. Genetics 179, 737–746 (2008).
Torres, E. M. et al. Identification of aneuploidy-tolerating mutations. Cell 143, 71–83 (2010).
Chikashige, Y. et al. Gene expression and distribution of Swi6 in partial aneuploids of the fission yeast Schizosaccharomyces pombe. Cell Struct. Funct. 32, 149–161 (2007).
Mao, R., Zielke, C. L., Ronald Zielke, H. & Pevsner, J. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics 81, 457–467 (2003).
Kurnit, D. M. Down syndrome: gene dosage at the transcriptional level in skin fibroblasts. Proc. Natl Acad. Sci. USA 76, 2372–2375 (1979).
Guo, M. & Birchler, J. A. Trans-acting dosage effects on the expression of model gene systems in maize aneuploids. Science 266, 1999–2002 (1994).
Kim, J. C. et al. Integrative analysis of gene amplification in Drosophila follicle cells: parameters of origin activation and repression. Genes Dev. 25, 1384–1398 (2011).
Stenberg, P. & Larsson, J. Buffering and the evolution of chromosome-wide gene regulation. Chromosoma 120, 213–225 (2011).
Larsson, J., Chen, J. D., Rasheva, V., Rasmuson-Lestander, A. & Pirrotta, V. Painting of fourth, a chromosome-specific protein in Drosophila. Proc. Natl Acad. Sci. USA 98, 6273–6278 (2001).
Miclaus, M., Xu, J.-H. & Messing, J. Differential gene expression and epiregulation of alpha zein gene copies in maize haplotypes. PLoS Genet. 7, e1002131 (2011).
Futcher, B. & Carbon, J. Toxic effects of excess cloned centromeres. Mol. Cell. Biol. 6, 2213–2222 (1986).
Oromendia, A. B., Dodgson, S. E. & Amon, A. Aneuploidy causes proteotoxic stress in yeast. Genes Dev. 26, 2696–2708 (2012).
Girirajan, S., Campbell, C. D. & Eichler, E. E. Human copy number variation and complex genetic disease. Annu. Rev. Genet. 45, 203–226 (2011).
Tang, Y.-C. & Amon, A. Gene copy-number alterations: a cost-benefit analysis. Cell 152, 394–405 (2013).
Isacson, O., Seo, H., Lin, L., Albeck, D. & Granholm, A. C. Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh. Trends Neurosci. 25, 79–84 (2002).
Hanemann, C. O. & Müller, H. W. Pathogenesis of Charcot–Marie–Tooth 1A (CMT1A) neuropathy. Trends Neurosci. 21, 282–286 (1998).
Katz, W., Weinstein, B. & Solomon, F. Regulation of tubulin levels and microtubule assembly in Saccharomyces cerevisiae: consequences of altered tubulin gene copy number. Mol. Cell. Biol. 10, 5286–5294 (1990).
Moriya, H., Makanae, K., Watanabe, K., Chino, A. & Shimizu-Yoshida, Y. Robustness analysis of cellular systems using the genetic tug-of-war method. Mol. Biosyst. 8, 2513–2522 (2012).
Deutschbauer, A. M. et al. Mechanisms of haploinsufficiency revealed by genome-wide profiling in yeast. Genetics 169, 1915–1925 (2005).
Kim, D.-U. et al. Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe. Nat. Biotechnol. 28, 617–623 (2010).
Das, I. et al. Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model. Sci. Transl. Med. 5, 201ra120 (2013).
Jiang, J. et al. Translating dosage compensation to trisomy 21. Nature 500, 296–300 (2013).
Bonney, M. E., Moriya, H. & Amon, A. Aneuploid proliferation defects in yeast are not driven by copy number changes of a few dosage sensitive genes. Genes Dev. 29, 898–903 (2015).
Sheltzer, J. M., Torres, E. M., Dunham, M. J. & Amon, A. Transcriptional consequences of aneuploidy. Proc. Natl Acad. Sci. 109, 12644–12649 (2012).
Foijer, F. et al. Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress. Proc. Natl Acad. Sci. 111, 13427–13432 (2014).
Dürrbaum, M. et al. Unique features of the transcriptional response to model aneuploidy in human cells. BMC Genomics 15, 139 (2014).
Gasch, A. P. Comparative genomics of the environmental stress response in ascomycete fungi. Yeast 24, 961–976 (2007).
Gasch, A. P. et al. Genomic expression programs in the response of yeast cells to environmental changes. Mol. Biol. Cell 11, 4241–4257 (2000).
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38, 1043–1048 (2006).
Venet, D., Dumont, J. E. & Detours, V. Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput. Biol. 7, e1002240 (2011).
Sheltzer, J. M. A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis. Cancer Res. 73, 6401–6412 (2013).
Simpson, M. V. The release of labeled amino acids from the proteins of rat liver slices. J. Biol. Chem. 201, 143–154 (1953).
Balch, W. E., Morimoto, R. I., Dillin, A. & Kelly, J. W. Adapting proteostasis for disease intervention. Science 319, 916–919 (2008).
Tyedmers, J., Mogk, A. & Bukau, B. Cellular strategies for controlling protein aggregation. Nat. Rev. Mol. Cell Biol. 11, 777–788 (2010).
Dobson, C. M. Protein folding and misfolding. Nature 426, 884–890 (2003).
Jahn, T. R. & Radford, S. E. The Yin and Yang of protein folding. FEBS J. 272, 5962–5970 (2005).
Kirkin, V., McEwan, D. G., Novak, I. & Dikic, I. A role for ubiquitin in selective autophagy. Mol. Cell 34, 259–269 (2009).
Ding, W.-X. & Yin, X.-M. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 4, 141–150 (2008).
Taipale, M., Jarosz, D. F. & Lindquist, S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat. Rev. Mol. Cell Biol. 11, 515–528 (2010).
Donnelly, N., Passerini, V., Dürrbaum, M., Stingele, S. & Storchova, Z. HSF1 deficiency and impaired HSP90-dependent protein folding are hallmarks of aneuploid human cells. EMBO J. 33, 2374–2387 (2014). This study shows that HSP90-mediated protein folding is reduced in aneuploid mammalian cells, providing a link between aneuploidy and proteotoxic stress.
Boulon, S. et al. HSP90 and its R2TP/prefoldin-like cochaperone are involved in the cytoplasmic assembly of RNA polymerase II. Mol. Cell 39, 912–924 (2010).
Li, G.-W., Burkhardt, D., Gross, C. & Weissman, J. S. Quantifying absolute protein synthesis rates reveals principles underlying allocation of cellular resources. Cell 157, 624–635 (2014).
Niwa, O., Tange, Y. & Kurabayashi, A. Growth arrest and chromosome instability in aneuploid yeast. Yeast 23, 937–950 (2006).
Segal, D. J. & McCoy, E. E. Studies on Down's syndrome in tissue culture. I. Growth rates and protein contents of fibroblast cultures. J. Cell. Physiol. 83, 85–90 (1974).
Thorburn, R. R. et al. Aneuploid yeast strains exhibit defects in cell growth and passage through START. Mol. Biol. Cell 24, 1274–1289 (2013).
Baker, D. J. et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat. Genet. 36, 744–749 (2004).
Weaver, B. A. A., Silk, A. D., Montagna, C., Verdier-Pinard, P. & Cleveland, D. W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11, 25–36 (2007).
Babu, J. R. et al. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J. Cell Biol. 160, 341–353 (2003).
Makanae, K., Kintaka, R., Makino, T., Kitano, H. & Moriya, H. Identification of dosage-sensitive genes in Saccharomyces cerevisiae using the genetic tug-of-war method. Genome Res. 23, 300–311 (2013).
Mitelman, F., Johansson, B. & Mertens, F. Mitelman database of chromosome aberrations and gene fusions in cancer. [online], (2014).
Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899–905 (2010).
Cahill, D. P. et al. Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics 58, 181–187 (1999).
Haruki, N. et al. Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers. Cancer Lett. 162, 201–205 (2001).
Gemma, A. et al. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer. Genes Chromosomes Cancer 29, 213–218 (2000).
Manning, A. L., Longworth, M. S. & Dyson, N. J. Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev. 24, 1364–1376 (2010).
Manning, A. L. & Dyson, N. J. pRB, a tumor suppressor with a stabilizing presence. Trends Cell Biol. 21, 433–441 (2011).
Tighe, A. Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability. J. Cell Sci. 117, 6339–6353 (2004).
Davoli, T. et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155, 948–962 (2013). By analysing genome sequence data from cancerous and normal tissues, this study provides evidence that aneuploidy drives tumorigenesis through losses of tumour-suppressor genes and gains of oncogenes.
Sussan, T. E., Yang, A., Li, F., Ostrowski, M. C. & Reeves, R. H. Trisomy represses ApcMin-mediated tumours in mouse models of Down's syndrome. Nature 451, 73–75 (2008).
Hasle, H. et al. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355, 165–169 (2001).
Baek, K.-H. et al. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459, 1126–1130 (2009).
Paulsson, K. & Johansson, B. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes. Pathol. Biol. 55, 37–48 (2007).
Jones, L. et al. Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. J. Exp. Med. 207, 2581–2594 (2010).
Greenberg, R. A. et al. Short dysfunctional telomeres impair tumorigenesis in the INK4aΔ2/3 cancer-prone mouse. Cell 97, 515–525 (1999).
Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999).
Sotillo, R., Schvartzman, J.-M., Socci, N. D. & Benezra, R. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 464, 436–440 (2010). This study shows that tumour relapse after oncogene withdrawal is accelerated under conditions of increased chromosome mis-segregation in a KRAS -driven model of lung cancer. This finding indicates that aneuploidy can facilitate the emergence of resistant karyotypes that confer an evolutionary advantage to the tumour.
Silk, A. D. et al. Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors. Proc. Natl Acad. Sci. 110, E4134–E4141 (2013). This article suggests that, although low levels of chromosome mis-segregation can accelerate the generation of karyotypes that promote tumorigenesis, high rates of chromosome gain and loss lead to tumour suppression and cell death.
Zhu, J., Pavelka, N., Bradford, W. D., Rancati, G. & Li, R. Karyotypic determinants of chromosome instability in aneuploid budding yeast. PLoS Genet. 8, e1002719 (2012).
Sheltzer, J. M. et al. Aneuploidy drives genomic instability in yeast. Science 333, 1026–1030 (2011).
Rancati, G. et al. Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell 135, 879–893 (2008).
Selmecki, A., Forche, A. & Berman, J. Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313, 367–370 (2006).
Yona, A. H. et al. Chromosomal duplication is a transient evolutionary solution to stress. Proc. Natl Acad. Sci. 109, 21010–21015 (2012).
Chen, G. et al. Targeting the adaptability of heterogeneous aneuploids. Cell 160, 771–784 (2015).
London, N. & Biggins, S. Signalling dynamics in the spindle checkpoint response. Nat. Rev. Mol. Cell Biol. 15, 736–747 (2014).
Cimini, D. et al. Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J. Cell Biol. 153, 517–527 (2001).
Niwa, O., Matsumoto, T. & Yanagida, M. Construction of a mini-chromosome by deletion and its mitotic and meiotic behaviour in fission yeast. Mol. Gen. Genet. 203, 397–405 (1986).
Weaver, B. A. A. & Cleveland, D. W. Does aneuploidy cause cancer? Curr. Opin. Cell Biol. 18, 658–667 (2006).
Niwa, O., Matsumoto, T., Chikashige, Y. & Yanagida, M. Characterization of Schizosaccharomyces pombe minichromosome deletion derivatives and a functional allocation of their centromere. EMBO J. 8, 3045–3052 (1989).
Zeng, Y., Li, H., Schweppe, N. M., Hawley, R. S. & Gilliland, W. D. Statistical analysis of nondisjunction assays in Drosophila. Genetics 186, 505–513 (2010).
Gregg, T. G. & Day, J. W. Nondisjunction of the X chromosomes in females of Drosophila hydei. Genetica 36, 172–182 (1965).
Koehler, K. E., Hawley, R. S., Sherman, S. & Hassold, T. Recombination and nondisjunction in humans and flies. Hum. Mol. Genet. 5, 1495–1504 (1996).
Bond, D. J. & Chandley, A. C. Aneuploidy (Oxford Monographs on Medical Genetics) (Oxford University Press, 1983).
Martin, R. H., Ko, E. & Rademaker, A. Distribution of aneuploidy in human gametes: comparison between human sperm and oocytes. Am. J. Med. Genet. 39, 321–331 (1991).
Martin, R. H. & Rademaker, A. The frequency of aneuploidy among individual chromosomes in 6,821 human sperm chromosome complements. Cytogenet. Cell Genet. 53, 103–107 (1990).
Templado, C., Vidal, F. & Estop, A. Aneuploidy in human spermatozoa. Cytogenet. Genome Res. 133, 91–99 (2011).
Pellestor, F., Andréo, B., Anahory, T. & Hamamah, S. The occurrence of aneuploidy in human: lessons from the cytogenetic studies of human oocytes. Eur. J. Med. Genet. 49, 103–116 (2006).
Pacchierotti, F., Adler, I.-D., Eichenlaub-Ritter, U. & Mailhes, J. B. Gender effects on the incidence of aneuploidy in mammalian germ cells. Environ. Res. 104, 46–69 (2007).
Obradors, A. et al. Whole-chromosome aneuploidy analysis in human oocytes: focus on comparative genomic hybridization. Cytogenet. Genome Res. 133, 119–126 (2011).
Nagaoka, S. I., Hassold, T. J. & Hunt, P. A. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat. Rev. Genet. 13, 493–504 (2012).
The authors apologize to our colleagues whose work we were not able to cite owing to space limitations. Work in the Amon laboratory is supported by grants from the US National Institutes of Health (GM56800), the Howard Hughes Medical Institute and the Kathy and Curt Marble Cancer Research Fund. S.S. was supported by the American Italian Cancer Foundation and by a Fellowship in Cancer Research from Marie Curie Actions and the Italian Association for Cancer Research.
The authors declare no competing financial interests.
- Spectral karyotyping
(SKY). A cytogenetic technique used to simultaneously visualize all chromosomes in a cell by using different fluorescently labelled probes for each chromosome.
A process in which entire chromosomes become fragmented and then are repaired in a seemingly random manner, leading to dozens (sometimes even hundreds) of rearrangements within a single chromosome.
- Dosage compensation
Alteration of mRNA or protein expression to compensate for variation in DNA copy number.
- Chromosomal instability
(CIN). A condition in which the rate of chromosome mis-segregation is elevated.
- Proteotoxic stress
A cellular stress elicited by unfolded and/or misfolded proteins.
About this article
Cite this article
Santaguida, S., Amon, A. Short- and long-term effects of chromosome mis-segregation and aneuploidy. Nat Rev Mol Cell Biol 16, 473–485 (2015) doi:10.1038/nrm4025
Journal of Cellular Physiology (2019)
Chromosome Missegregation and Aneuploidy Induction in Human Peripheral Blood Lymphocytes In vitro by Low Concentrations of Chlorpyrifos, Imidacloprid and α-Cypermethrin
Environmental and Molecular Mutagenesis (2019)
The molecular origins and pathophysiological consequences of micronuclei: New insights into an age-old problem
Mutation Research/Reviews in Mutation Research (2019)
Risks of aneuploidy induction from chemical exposure: Twenty years of collaborative research in Europe from basic science to regulatory implications
Mutation Research/Reviews in Mutation Research (2019)